Overall Technical outlook

Price Summary

Glenmark Pharmaceuticals Limited's stock opened at 2039.3 on 2025-08-14, surged to 2052.8, dropped to 2017.0, and ended 0.26% up at 2044.6, with 986277 shares traded.
In the 52-week period, the stock's peak price is 2226.7, and the lowest price recorded is 1278.95.
Analysts' predictions indicate that GLENMARK's future price will be between 1500.0 and 2934.0, with a mean price expectation of approximately 2124.182.

Technicals

Support and Resistance: At 2044.6, the price is supported by 1860.1 and resisted by 2144.2. This indicates that the price for Glenmark Pharmaceuticals Limited might fluctuate between these levels, with 1860.1 acting as a support and 2144.2 limiting further upward movement.
GLENMARK supportResistance 548a53
Support/Resistance for GLENMARK


Aroon: The current state of the AROON is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
GLENMARK aroon 548a53
Aroon chart for Glenmark Pharmaceuticals Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
GLENMARK bbands 548a53
Bolinger Bands chart for Glenmark Pharmaceuticals Limited


Parabolic SAR: The PSAR continues its bearish trend, setting a resistance level that could prevent significant upward movement for GLENMARK. This resistance suggests that the market may struggle to overcome bearish forces, keeping upward momentum in check.
GLENMARK psar 548a53
Parabolic Stop and Reverse chart for Glenmark Pharmaceuticals Limited


Stochastic: The current state of the STOCHASTIC is neutral for GLENMARK, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
GLENMARK stoch 548a53
Stochastic chart for Glenmark Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
GLENMARK trippleSMA 548a53
Tripple SMA chart for Glenmark Pharmaceuticals Limited


The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.